Medscape: New drug reduces tics in Tourette syndrome patients without major side effects
A new study shows that an investigational drug helps reduce tics and is safe for children with Tourette syndrome (TS).
TS, a neurological condition that causes sudden repetitive involuntary muscle movements and sounds known as tics, typically develops in childhood and worsens during adolescence.
Donald Gilbert, MD, study investigator, professor of pediatrics in the University of Cincinnati College of Medicine and a pediatric movement disorders and TS specialist at Cincinnati Children's Hospital Medical Center, told Medscape the study results seem to indicate that "help is on the way" for patients looking for an effective treatment for TS without side effects like weight gain, anxiety or depression.
"There may be a drug available with a new mechanism of action that is effective to suppress tics without causing weight gain or unwanted neuropsychiatric side effects," Gilbert said.
The study findings will be formally presented at the American Academy of Neurology 2022 annual meeting in April.
Featured photo at top courtesy of Pixabay.
Related Stories
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.
UC Board of Trustees approves $12 million for building design phase for new welcome gateway
March 13, 2026
The UC Board of Trustees approved $12 million at its Feb. 24 meeting for the design phase of a new Welcome Gateway Building for Uptown campus.